Hemostatic therapy should not be used for acute treatment of anticoagulation-related intracerebral hemorrhage.
Department of Neurology, APHP-Hôpital Lariboisière, 2, rue Ambroise Paré, 75475 Paris cedex 10, France. christian.stapf@lrb.aphp.fr
Christian
C
Stapf
D000925:Anticoagulants / Q000009:adverse effects*; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000628:therapy*; D015942:Factor VIIa / Q000627:therapeutic use; D006489:Hemostatic Techniques / Q000009:adverse effects*; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D019934:International Normalized Ratio; D010949:Plasma; D011516:Prothrombin / Q000627:therapeutic use; D014812:Vitamin K / Q000627:therapeutic use
D000925:Anticoagulants; D006490:Hemostatics; D014812:Vitamin K; D011516:Prothrombin; D015942:Factor VIIa